fda declaratory order semaglutide shortage resolved GLP-1 Drugs: Removes from the Drug List GLP-1 Saga Continues: FDA Ends

GLP-1 medications are generally safe and well-tolerated, but in rare instances, they can cause serious issues

Liver Disease (MASLD/NAFLD) Metabolic dysfunction-associated steatotic liver disease (MASLD) formerly known as nonalcoholic fatty liver disease (NAFLD) involves a buildup of fat in the liver that often occurs alongside metabolic disorders such as obesity and insulin resistance

[1] [2] Injecting cold medication directly from the refrigerator may increase the likelihood of injection site reactions

19 , 20 Oxidation of cysteine side chains eliminates proteinsulfhydryl (SH) groups with the formation of proteinprotein disulfide crosslinks or mixed disulfides between proteinSH groups and the low molecular weight thiols cysteine and glutathione